Company news
Bide Pharmatech Co. Ltd. Class A (SSE:688073) news
Bide Pharmatech Co. Ltd. Class A news releases on 6ix. Latest, Apr 15, 2025: Announcement on Resolution of the 19th Meeting of the 2nd Board of Directors
Press releases — page 2
Announcement on Resolution of the 19th Meeting of the 2nd Board of Directors
April 14, 2025
Announcement on Repurchasing 1% of the Company's Share Capital through Call Auction and Repurchase Progress
April 7, 2025
Announcement on Progress in Planning Major Asset Restructuring and Risk Warning
March 28, 2025
Announcement on Appointment of Chief Financial Officer
March 24, 2025
Announcement on the Resignation of Directors, Secretary of the Board and Chief Financial Officer
March 11, 2025
Announcement on Initially Repurchasing Shares through Call Auction
March 6, 2025
Announcement on Progress in Planning Major Asset Restructuring
February 27, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2025
February 24, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders without Sales Restrictions Concerning Shares Repurchase
February 21, 2025
Announcement on Resolution of the 17th Meeting of the 2nd Board of Directors
February 7, 2025